To check whether your prescription is on the blood pressure medication recall list, match three details from your bottle against the FDA Enforcement Report: drug name and strength, manufacturer, and lot number. The lot is the one that decides it.
As of the FDA’s August 19, 2026 data update, the 2026 list holds 20 blood pressure entries, 19 Class II and one Class III. The newest is Diovan 160 mg lot AV5913C (Novartis, recall began August 4).
The drug-by-drug table is in our 2026 blood pressure medication recall roundup; this article is the checking procedure.
Where the recall list actually lives
The master list is the FDA Enforcement Report. It publishes weekly and includes every recall the FDA monitors, Class I, II or III, plus entries marked “not yet classified” while the hazard assessment is still running.
Company notices appear earlier, on the FDA’s Recalls, Market Withdrawals and Safety Alerts page. The FDA notes that firms often post well before classification is complete, so check both.
Three features of the report matter for a repeat check. Keyword email alerts send you every new or updated entry that mentions your drug name, and the same data is exposed through a public API, which is how this site pulls the 2026 count.
The History feature records later changes to an entry’s classification, reason for recall, code information and product description. A lot list that grows after the first posting stays visible instead of being silently overwritten.
The identifiers on your bottle, and where each sits in the FDA record
This table maps a pharmacy vial to the Enforcement Report’s own field names.
| Identifier | On your pharmacy vial | In the Enforcement Report entry |
|---|---|---|
| Drug name and strength | Printed on the label, e.g. metoprolol succinate ER 50 mg | Product description |
| Manufacturer | Usually printed, often abbreviated (Teva, Ascend, Unichem) | Recalling firm |
| NDC | The FDA’s three-segment drug identifier; printing varies by pharmacy | Product description, e.g. NDC 45963-676 on Teva metoprolol 50 mg |
| Lot number and expiry | Rarely on the vial; it stays on the stock bottle behind the counter | Code information |
Two bottles of the same drug from the same firm can differ only by lot, and only some lots are recalled.
Step by step: matching your bottle to the list
First, read the label for name, strength and manufacturer. Metoprolol succinate ER from Teva puts you in the zone of a 2026 entry; lisinopril from any firm does not, because no lisinopril entry exists this year.
Second, open the Enforcement Report quick search, type the drug name and restrict to Drugs. Compare firm, strength and package size against your vial. The status field reads Ongoing for all 20 blood pressure entries.
Third, call the pharmacy with your fill date and ask them to compare the stock-bottle lot against the entry’s code information. They keep that record; you almost never do.
Repeat the check at every refill, since a new fill can come from a different lot or manufacturer. The same pharmacy record separates prescription vitamin D2 from over-the-counter D3.
If your bottle is on the list
Read the class first. Under the FDA’s definitions, Class II means use “may cause temporary or medically reversible adverse health consequences” or that the chance of serious harm is remote. Class III means adverse effects are not likely. No 2026 blood pressure entry is Class I.
Recall notices for these products direct patients to a pharmacist or prescriber rather than stopping on their own. Stopping a blood pressure drug abruptly carries its own risk, and the pharmacy can usually swap you to an unaffected lot or manufacturer.
If a recalled product caused you a problem, report it through MedWatch, the FDA’s safety reporting program for patients and health professionals. Supplements sold for heart support, such as magnesium taurate, are not a stand-in for a recalled prescription.
This is general information drawn from FDA public records, not medical advice; decisions about your prescription belong with your pharmacist and prescriber.
Does the pharmacy label show the lot number?
Usually not. Retail vials are filled from a larger stock bottle, and the manufacturer’s lot and expiry stay on that bottle, which your pharmacy can trace.
Is losartan on the 2026 recall list?
No. As of the FDA’s August 19, 2026 enforcement data there is no losartan, irbesartan or telmisartan entry for the year. The 20 entries that do exist are listed drug by drug in the roundup linked above.
How often does the recall list update?
The Enforcement Report publishes weekly, and entries are updated when a classification or lot list changes. Company notices can reach the FDA recalls page weeks earlier.